Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in experienced patients

被引：0

作者：

Marcelin, A ^{[1
]}

Roquebert, B ^{[1
]}

Malet, I ^{[1
]}

Wirden, M ^{[1
]}

Simon, A ^{[1
]}

Katlama, C ^{[1
]}

Calvez, V ^{[1
]}

机构：

[1] Hop La Pitie Salpetriere, Dept Virol, Paris, France

来源：

ANTIVIRAL THERAPY | 2005年 / 10卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：S98 / S98

页数：1

共 50 条

[21] RNASE-H DOMAIN OF HIV-1 REVERSE-TRANSCRIPTASE [J].

HOSTOMSKA, Z ;

HOSTOMSKY, Z ;

DAVIES, J ;

MATTHEWS, D .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) :860-860

[22] Structural Characteristics of the RNAse H Domain in HIV-1 Reverse Transcriptase [J].

Slack, Ryan L. ;

Sharaf, Naima G. ;

Gronenborn, Angela M. ;

Ishima, Rieko .

BIOPHYSICAL JOURNAL, 2017, 112 (03) :487A-487A

[23] Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients [J].

Magiorkinis, E ;

Paraskevis, D ;

Lazanas, M ;

Kiosses, VG ;

Gargalianos, P ;

Hatzakis, A .

AIDS, 1999, 13 (10) :1276-1278

[24] A survey of resistance mutations to reverse transcriptase inhibitors (RTIs) among HIV-1 patients in northeast of Iran [J].

Mazaheri, Zahra ;

Tahaghoghi-Hajghorbani, Sahar ;

Baesi, Kazem ;

Ghazvini, Kiarash ;

Amel-Jamehdar, Saeid ;

Youssefi, Masoud .

MOLECULAR BIOLOGY RESEARCH COMMUNICATIONS, 2024, 13 (03) :117-125

[25] Specific mutations related to resistance to HIV-1 integrase inhibitors are associated with reverse transcriptase mutations in HAART-treated patients [J].

Ceccherini-Silberstein, F. ;

Malet, I. ;

Fabeni, L. ;

Svicher, V. ;

Gori, C. ;

Dimonte, S. ;

Bono, S. ;

Artese, A. ;

D'Arrigo, R. ;

Katlama, C. ;

Antinori, A. ;

d'Arminio Montforte, A. ;

Calvez, V. ;

Marcelin, A. G. ;

Perno, C. F. .

ANTIVIRAL THERAPY, 2007, 12 :S6-S6

[26] Specific mutations related to resistance to HIV-1 integrase inhibitors are associated with reverse transcriptase mutations in HAART-treated patients [J].

Ceccherini-Silberstein, F. ;

Malet, I. ;

Fabeni, L. ;

Svicher, V. ;

Gori, C. ;

Dimonte, S. ;

Bono, S. ;

Artese, A. ;

D'Arrigo, R. ;

Katlama, C. ;

Antinori, A. ;

Monforte, A. d'Arminio ;

Calvez, V. ;

Marcelin, A. G. ;

Perno, C. F. .

ANTIVIRAL THERAPY, 2007, 12 (05) :S6-S6

[27] Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase [J].

Menendez-Arias, Luis .

VIRUS RESEARCH, 2008, 134 (1-2) :124-146

[28] Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals [J].

Ngcapu, Sinaye ;

Theys, Kristof ;

Libin, Pieter ;

Marconi, Vincent C. ;

Sunpath, Henry ;

Ndung'u, Thumbi ;

Gordon, Michelle L. .

VIRUSES-BASEL, 2017, 9 (11)

[29] Mechanisms of resistance of HIV-1 reverse transcriptase to nucleoside and non-nucleoside inhibitors [J].

Boyer, PL ;

Tantillo, C ;

Ding, J ;

Ferris, AL ;

Clark, P ;

Arnold, E ;

Hughes, SH .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 :6-6

[30] HIV-1 reverse transcriptase connection domain mutations reduce template RNA degradation and enhance nucleoside reverse transcriptase inhibitor excision [J].

Nikolenko, G. N. ;

Delviks-Frankenberry, K. A. ;

Boyer, P. L. ;

Hughes, S. H. ;

Coffin, J. M. ;

Jere, A. ;

Pathak, V. K. .

ANTIVIRAL THERAPY, 2008, 13 (04) :A60-A60

← 1 2 3 4 5 →